Supplements and Food Dangerous Interactions 1Coenzyme Q10Author Prof. Hayk S. Arakelyan Full Professor in Medicine, Doctor of Medical Sciences, Ph.D , Grand Ph.D Senior Expert of Interactive Clinical Pharmacology ,Treatment Tactics,General Medicine…Continue
Started by Hayk S. Arakelyan in Business Development Opportunities May 7.
Our team in the Advanced Academic Programs The Johns Hopkins University is trying to identify which project management tools are used most frequently and are most helpful in portfolio selection and risk management. A secondary objective is an…Continue
Started by Chris Breder in Business Development Opportunities Apr 12.
Filgrastim BS and Lantus BS Approval- Encouraging uptake and a lesson to fast track JP approval based on Ex-Japan data!Remicade biosimilar “NK” – A slow start does not pull back NK in starting PhIII for Herceptin BS in JapanActive companies in…Continue
Started by Jagdish Gohil in Contract Research & Manufacturing Opportunities Mar 10.
Sakigake designation – A Push from government to “Innovate”!“Essential drugs” exemption from Z2 rule- Balancing long listed pricing pressure!Authorized Generics, Biosimilars, and Patent Litigations - Avenues to grow in JP Generic market!Increasing…Continue
Started by Jagdish Gohil in Pharmaceutical Distribution & Licensing Opportunities Mar 10.
Introduction: In response to increasing drug integrity concerns, over 40 countries have introduced track and trace laws to help regulate product as it passes through the supply chain. By the end of 2018, more than 75% of the world's prescription…Continue
Started by Bogdan Berbece in Business Development Opportunities Nov 19, 2015.
George Clinical’s (GC) Dr Maria Ali has recently been appointed as a steering committee member of the Clinical Trials Transformation Initiative (CTTI). The CTTI comprises of more than 60 organizations from across clinical trial (CT) enterprise…Continue
A team of researchers led by Purdue University scientists Michael Rossmann and Richard Kuhn is the first to determine the structure of the Zika virus, which reveals insights critical to the development of effective antiviral treatments and…Continue
Scientists from Basel University and University Hospital Basel made an unexpected discovery on the growth of tumor cells, which brings new insight to the tumor development and possibility for new therapies on inhibiting tumor growth with…Continue
Fungus is the member in a big group which are made by eukaryotic organisms containing
microorganisms. Most of them are not detrimental to human body, but some will lead to
fungal disease. The reason is that biological compounds will be…
You are disconnected from chat. Connect to join the chat.
Sign up to chat on Pharma Connections Worldwide.